EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Small Sugar Molecule with Huge Potential in Targeted Cancer Therapy

Gabriela Pastuch-Gawołek iD, Julia Szreder, Monika Domińska iD, Mateusz Pielok, Piotr Cichy iD, Mirosława Grymel iD

Pharmaceutics · 11.03.2023 · 15 (3) · 913

DOI: 10.3390/pharmaceutics15030913 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 11.03.2023. Verfasst von Gabriela Pastuch-Gawołek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Bioorganic Chemistry and Biotechnology, Silesian University of Technology, B. Krzywoustego 4, 44-100 Gliwice, Poland. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 281 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Silesian University of Technology, Ministry of Education and Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The number of cancer-related diseases is still growing. Despite the availability of a large number of anticancer drugs, the ideal drug is still being sought that would be effective, selective, and overcome the effect of multidrug resistance. Therefore, researchers are still looking for ways to improve the properties of already-used chemotherapeutics. One of the possibilities is the development of targeted therapies. The use of prodrugs that release the bioactive substance only under the influence of factors characteristic of the tumor microenvironment makes it possible to deliver the drug precisely to the cancer cells. Obtaining such compounds is possible by coupling a therapeutic agent with a ligand targeting receptors, to which the attached ligand shows affinity and is overexpressed in cancer cells. Another way is to encapsulate the drug in a carrier that is stable in physiological conditions and sensitive to conditions of the tumor microenvironment. Such a carrier can be directed by attaching to it a ligand recognized by receptors typical of tumor cells. Sugars seem to be ideal ligands for obtaining prodrugs targeted at receptors overexpressed in cancer cells. They can also be ligands modifying polymers’ drug carriers. Furthermore, polysaccharides can act as selective nanocarriers for numerous chemotherapeutics. The proof of this thesis is the huge number of papers devoted to their use for modification or targeted transport of anticancer compounds. In this work, selected examples of broad-defined sugars application for improving the properties of both already-used drugs and substances exhibiting anticancer activity are presented.

Schlagwörter

Stichwörter der Autor:innen

drug carriersglycoconjugatesglycopolymersprodrugtargeted cancer therapy

Autor:innen und Institutionen

  • Department of Organic Chemistry, Bioorganic Chemistry and Biotechnology, Silesian University of Technology, B. Krzywoustego 4, 44-100 Gliwice, Poland.
  • Biotechnology Centre, Silesian University of Technology, B. Krzywoustego 8, 44-100 Gliwice, Poland.

ORCID-Profile: Gabriela Pastuch-Gawołek, Monika Domińska, Piotr Cichy, Mirosława Grymel

Förderung

  • Silesian University of Technology
  • Ministry of Education and Science

Zitieren

APA

Pastuch-Gawołek, G., Szreder, J., Domińska, M., Pielok, M., Cichy, P., & Grymel, M. (2023). A Small Sugar Molecule with Huge Potential in Targeted Cancer Therapy. Pharmaceutics, 15(3), 913. https://doi.org/10.3390/pharmaceutics15030913

Vancouver

Pastuch-Gawołek G, Szreder J, Domińska M, Pielok M, Cichy P, Grymel M. A Small Sugar Molecule with Huge Potential in Targeted Cancer Therapy. Pharmaceutics. 2023;15(3):913. doi:10.3390/pharmaceutics15030913

BibTeX
@article{PastuchGawoek2023,
  author = {Pastuch-Gawołek, Gabriela and Szreder, Julia and Domińska, Monika and Pielok, Mateusz and Cichy, Piotr and Grymel, Mirosława},
  title = {A Small Sugar Molecule with Huge Potential in Targeted Cancer Therapy},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {913},
  doi = {10.3390/pharmaceutics15030913}
}
Kostenlos starten →